Immune checkpoint inhibitor-induced inflammatory arthritis: a qualitative study identifying unmet patient needs and care gaps.
Laura C CappelliSuzanne M GriebAmi A ShahClifton O BinghamAna-Maria OrbaiPublished in: BMC rheumatology (2020)
As reported by patients, ICI-induced IA had a significant functional and emotional impact, even as compared to cancer and other ICI-induced side effects. Increasing awareness and integrated care of ICI-induced IA, and increasing social support are key targets for improving patient care. Additionally, more data on cancer outcomes in patients requiring immunomodulation for ICI-induced IA would help address fear and uncertainty for patients, and better support them through therapeutic decisions.
Keyphrases
- end stage renal disease
- high glucose
- ejection fraction
- social support
- newly diagnosed
- healthcare
- chronic kidney disease
- diabetic rats
- prognostic factors
- drug induced
- palliative care
- depressive symptoms
- oxidative stress
- squamous cell carcinoma
- insulin resistance
- case report
- machine learning
- patient reported
- prefrontal cortex
- childhood cancer